Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …

Background Assessing safety and efficacy of Covid-19 vaccines in different populations is
essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern …

There are conflicting reports on the effects of HIV on COVID-19. Here, we analyzed disease
severity and immune cell changes during and after SARS-CoV-2 infection in 236 participants …

HIV infection alters the immune response and can compromise protective immunity to
multiple pathogens following vaccination. We investigated the impact of HIV on the immune …

Mycobacterium tuberculosis (Mtb) bacilli readily aggregate. We previously reported that Mtb
aggregates lead to phagocyte death and subsequent efficient replication in the dead …

Introduction Current TB treatment regimens are pathogen-directed and can be severely
compromised by the development of drug resistance. Metformin has been proposed as an …

COVID-19 vaccine efficacy (VE) has been observed to vary against antigenically distinct
SARS-CoV-2 variants of concern (VoC). Here we report the final analysis of VE and safety from …

Viruses increase the efficiency of close-range transmission between cells by manipulating
cellular physiology and behavior, and SARS-CoV-2 uses cell fusion as one mechanism for cell…

One mechanism of variant formation may be evolution during long-term infection in
immunosuppressed people. To understand the viral phenotypes evolved during such infection, we …

The milder clinical manifestations of Omicron infection relative to pre-Omicron SARS CoV-2
raises the possibility that extensive evolution results in reduced pathogenicity. To test this …